Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate. Phillips TJ, Selmaj K, Gold R, Fox RJ, Havrdova E, Giovannoni G, Abourjaily H, Pace A, Novas M, Hotermans C, et al. Int J MS Care. 2015 Sep-Oct; 17(5):236-43. PMID: 26472945. Abstract CommentRecommendBookmarkWatch